Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation Read more about Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation
Xencor Reports Second Quarter 2015 Financial and Operating Results Read more about Xencor Reports Second Quarter 2015 Financial and Operating Results
Xencor to Present at 2015 Wedbush PacGrow Healthcare Conference Read more about Xencor to Present at 2015 Wedbush PacGrow Healthcare Conference
Xencor Appoints Yujiro S. Hata to Board of Directors Read more about Xencor Appoints Yujiro S. Hata to Board of Directors
Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 Read more about Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015
Xencor Provides Update on Two Lead XmAb® Product Candidates and Expansion of Bispecific Oncology Pipeline at R&D Day Read more about Xencor Provides Update on Two Lead XmAb® Product Candidates and Expansion of Bispecific Oncology Pipeline at R&D Day
Xencor to Host R&D Day and Webcast on June 26, 2015 Read more about Xencor to Host R&D Day and Webcast on June 26, 2015
Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting Read more about Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting
Xencor to Present at Jefferies 2015 Healthcare Conference Read more about Xencor to Present at Jefferies 2015 Healthcare Conference
Xencor, Inc. Appoints Mark Lotz, R.Ph., as Vice President of Regulatory Affairs and Wayne Saville, M.D., as Vice President of Clinical Oncology Read more about Xencor, Inc. Appoints Mark Lotz, R.Ph., as Vice President of Regulatory Affairs and Wayne Saville, M.D., as Vice President of Clinical Oncology
